BioNano Genomics Inc vs NextEra Energy, Inc. — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while NextEra Energy, Inc. trades at $85.8 (market cap $178.85B). The key difference: NextEra Energy, Inc. is far larger — about 13093× BioNano Genomics Inc's market cap, and NextEra Energy, Inc. pays a 2.91% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | NEE | |
|---|---|---|
Market Cap | $13.66M | $178.85B |
Sector | Health | Utilities |
52-Week High | $4.92 | $97.88 |
52-Week Low | $1.06 | $69.77 |
Enterprise Value | $16.26M | $286.18B |
Dividend Yield | — | 2.91% |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →